Authors: R. Rokyta Jr.; V. Šrámek; I. Novák; M. Matějovič; P. Hora; M. Nalos Authors‘ workplace: Metabolická jednotka intenzivní péče, I. interní klinika FN Plzeň, přednosta doc. MUDr. Karel Opatrný jr., CSc. Published in: Anest. intenziv. Med., , 2000, č. 2, s. 75-79 Category:
Acute renal failure (ARF; the most severe form of renal dysfunction) in the critically ill has a high mortality rate (50O80 %) and in most cases isa part of multiple organ dysfunction syndrome (MODS). The predominant cause of ARF in critically ill patients is acute tubular necrosis (ATN) dueto ischemia or nefrotoxic agents.The prevention of ARF is based on maintenance of adequate intravascular volume, cardiac output and renal perfusion pressure. The identificationand adequate monitoring of high-risk patients and the elimination of potential nefrotoxic agents is essential.We discuss the role of established pharmacological support (dopamine, diuretics, and calcium antagonists) as well as the place of some new agents(atrial natriuretic peptide, prostaglandins, adenosine antagonists and growth factors) in the prevention of ARF.
Key words: acute renal failure O intensive care O prophylaxis O acute tubular necrosis O nefrotoxin
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
